The purpose of this study is to explore any possible relationships between IL-6 serum titers in post-COVID-19 patients with or without vertigo during the active infection phase who were admitted to the COVID-19 internal medicine departments of Attikon University Hospital, Athens, Greece, within a time frame of 12 months. The gene discussed is IL6; the disease is COVID-19.